1. A genetic polymorphism affects the risk and prognosis of renal cell carcinoma: association with follistatin-like protein 1 expression
   Yan Liu et al, 2016, Scientific Reports CrossRef
2. Allelic loss at chromosome 11q13 alters FGF3 gene expression in a human breast cancer progression model
   DEBASISH ROY et al, 2014, Oncology Reports CrossRef
3. A novel functional polymorphism of GSTM3 reduces clear cell renal cell carcinoma risk through enhancing its expression by interfering miR‐556 binding
   Ying Wang et al, 2018, Journal of Cellular and Molecular Medicine CrossRef
4. Prognostic Significance of Cyclin D1 Expression in Renal Cell Carcinoma: a Systematic Review and Meta-analysis
   Zeyan Li et al, 2020, Pathology & Oncology Research CrossRef
5. Prognostic Roles of Phosphofructokinase Platelet in Clear Cell Renal Cell Carcinoma and Correlation with Immune Infiltration
   Bin Liu et al, 2021, International Journal of General Medicine CrossRef
6. Molecular Genetics of Renal Cell Carcinoma
   Tomoya Fukawa et al, 2017, Renal Cell Carcinoma CrossRef
7. Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
   Johannes Schödel et al, 2016, European Urology CrossRef
8. Racial Disparities and Preventive Measures to Renal Cell Carcinoma
   Jennifer Sims et al, 2018, International Journal of Environmental Research and Public Health CrossRef
9. Variants ofSCARB1andVDRInvolved in Complex Genetic Interactions May Be Implicated in the Genetic Susceptibility to Clear Cell Renal Cell Carcinoma
   Ewelina Pośpiech et al, 2015, BioMed Research International CrossRef
10. Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression
    X Tan et al, 2013, British Journal of Cancer CrossRef